Manufacturing

Articles

The companies have entered into a manufacturing agreement for the fill finish supply of lenzilumab for the potential treatment of COVID-19.

Ajinomoto Bio-Pharma Services, Humanigen in Manufacturing Agreement for COVID-19 Biologic

The acquisition gives Novovax an annual operating capacity of more that one billion doses of COVID-19 vaccine antigen.

Novavax Acquires Praha Vaccines, Expands Large-Scale Vaccine Manufacturing Capacity

The companies have formed a collaboration to develop a novel human recombinant protein as a therapeutic candidate against COVID-19.


Airway Therapeutics, Celonic Group Partner on New COVID-19 Therapeutic

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

US manufacturers focus on preparing capacity while vaccines and treatments for COVID-19 are being developed and tested.

Preparing to Meet Manufacturing Needs During a Pandemic

This latest round of funding adds 14 new technology projects, workforce development, and Global Health Fund projects to NIIMBL's portfolio.

NIIMBL Funds Projects with $10 Million for Advances in Biopharma Manufacturing Innovation

Brandon Haschke is a product manager for Emerson's Rosemount instrumentation business. 

Single-use processing requires instruments providing the accuracy of traditional technologies but configured in form factors designed specifically for this service

Instrumenting Single-Use Processes

Synthetic depth filters are a suitable option to provide a high-performance and scalable single-step clarification process.

Optimizing Viral Vector Manufacturing for Gene Therapy

The company will invest $180 million to construct a new 290,000-ft2 facility in Plainville, MA.

Thermo Fisher Scientific to Double Viral Vector Manufacturing Capacity

Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma entered into long-term development and manufacturing services agreements for the clinical and commercial supply of multiple bluebird bio therapies.

HCATS, apceth Biopharma Form Strategic Manufacturing Agreements with bluebird bio

Catalent will manufacture a mRNA-based COVID-19 vaccine for clinical trials and potential commercialization.

Manufacturing, Biologic Drugs